Intramuscular gene transfer of apolipoprotein E (ApoE) to reverse hyperlipidaemia and atherosclerosis in ApoE-deficient mice
Plasma ApoE has multiple atheroprotective actions, including clearance of cholesterol-rich remnant lipoproteins, and is an attractive gene therapy candidate to treat atherosclerosis. Here, I focus on the single intramuscular injection of an ApoE-expressing vector, non-viral DNA (plasmid) or adeno-as...
Main Author: | Evans, Vanessa |
---|---|
Published: |
University College London (University of London)
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498138 |
Similar Items
-
Chlamydia Pheunomiae and atherosclerosis
by: Arno, Gavin
Published: (2007) -
Chlamydia pneumoniae infection and atherosclerosis
by: Smith, Dr David Andrew
Published: (2004) -
Development of recombinant adeno-associated virus and second generation adenovirus vectors for the gene transfer of human apolipoprotein E (ApoE) in the APOE deficient mouse
by: Harris, Julian David
Published: (2005) -
The Effects of Psychosocial Stress on the Development of Atherosclerosis
by: Schwartz, Claire
Published: (2009) -
Investigating of the mechanisms underlying the development of the atherosclerosis
by: Kelly, D. M.
Published: (2010)